HUPO 2026 has ended. This guide stays up as the record of who was there. See upcoming conferences

All India Institute of Medical Sciences, New Delhi at HUPO 2026

Sep 27 – Oct 1, 2026 Singapore ~1.8k attendees Website

All India Institute of Medical Sciences, New Delhi brings 5 presentations to HUPO 2026 in Singapore. Its work centres on liver disease biomarkers, especially acute-on-chronic liver failure and fibrosis staging in MASLD. It also reports plasma metallothioneins as predictors of acute kidney injury in liver failure, and AGK as the target through which sesamolin boosts cisplatin in ovarian cancer.

OrganizationHUPO 2026 Attendance
Universities & research institutes
Public medical university and hospital in New Delhi, India.
Poster
Wed Sep 30
1:15pm–3:00pm
Circulating Plasma Lipidome Influences Leukocyte TLR and CD177 Gene Expression in Acute-on-Chronic Liver Failure (ACLF)
Board PS03.103
Clinical · Multi-omics
Collaborators: University of Nebraska Medical Center

Explore the full HUPO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Singapore. Leave your work email and we’ll be in touch.

Privacy

Download the full HUPO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from All India Institute of Medical Sciences, New Delhi

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the Human Proteome Organization (HUPO) or the HUPO 2026 World Congress. Submit a correction